These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5531293)

  • 1. Convulsive seizures and electroencephalogram changes in three patients during levodopa therapy.
    McPherson A
    Neurology; 1970 Dec; 20(12):41-5. PubMed ID: 5531293
    [No Abstract]   [Full Text] [Related]  

  • 2. Convulsive seizures and electroencephalogram changes in three patients during levodopa therapy.
    McPherson A
    Neurology; 1970 Dec; 20(12):Suppl:41-5. PubMed ID: 5529914
    [No Abstract]   [Full Text] [Related]  

  • 3. Electroencephalographic changes occurring during L-dopa treatment.
    Herman MN; Rowan AJ; Goldensohn ES
    Trans Am Neurol Assoc; 1971; 96():252-4. PubMed ID: 5159096
    [No Abstract]   [Full Text] [Related]  

  • 4. EEG and urinary non-catecholic amine changes during L-dopa therapy of Parkinson's disease.
    Marjerrison G; Boulton AA; Rajput AH
    Dis Nerv Syst; 1972 Mar; 33(3):164-9. PubMed ID: 5022451
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of 3,4-dihydroxyphenylalanine (levodopa) in hepatic coma].
    González-Posada J; Hernández-Peniche J; Tirado-Arroyave S
    Arch Invest Med (Mex); 1972; 3(1):1-6. PubMed ID: 5037838
    [No Abstract]   [Full Text] [Related]  

  • 6. [L-DOPA therapy of parkinsonism].
    Refsum S
    Nord Med; 1969 May; 81(18):570-1. PubMed ID: 5768311
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural-functional organization of the human brain and the pathophysiology of the Parkinsonian type hyperkineses.
    Bechtereva NP; Bondartchuk AN; Gretchin VB; Iliukhina VA; Kambarova DK; Matveev YK; Petushkov EP; Pozdeev VK; Smirnov VM; Shandurina AN
    Confin Neurol; 1972; 34(1):14-7. PubMed ID: 4563544
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness and limitations of long-term levodopa therapy in Parkinsonism.
    Celesia GG; Barr AN
    Wis Med J; 1970 Oct; 69(10):227-9. PubMed ID: 5472626
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychiatric changes in patients treated with levodopa. I. The clinical experiment.
    Knopp W
    Neurology; 1970 Dec; 20(12):23-30. PubMed ID: 4924341
    [No Abstract]   [Full Text] [Related]  

  • 10. The Eaton Collaborative Study of levodopa therapy in parkinsonism: a summary.
    Keenan RE
    Neurology; 1970 Dec; 20(12):46-59. PubMed ID: 5531294
    [No Abstract]   [Full Text] [Related]  

  • 11. [Physiopathology and symptomatology of parkinsonian movement disorders in the light of recent therapeutic progress].
    Ferrari E
    Sist Nerv; 1970; 22(2):164-74. PubMed ID: 4926919
    [No Abstract]   [Full Text] [Related]  

  • 12. [Initial experiences with Levodopa in the treatment of the Parkinsonian syndrome].
    Beteta E; Gonzales-Portillo MA; Voto Bernales J
    Rev Neuropsiquiatr; 1970 Jun; 33(2):136-45. PubMed ID: 5509274
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergism of levodopa by alpha methyldopa.
    Fermaglich J; O'Doherty DS
    Trans Am Neurol Assoc; 1971; 96():231-4. PubMed ID: 5159089
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of L-dopa on the EEG and EMG in Parkinson patients.
    Visser SL; Postma JU
    Psychiatr Neurol Neurochir; 1971; 74(4):315-21. PubMed ID: 5146237
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Parkinson's syndrome with levodopa].
    Rossi CA
    Prensa Med Argent; 1970 Oct; 57(31):1516-8. PubMed ID: 5485492
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dynamics of slow potential changes in human subcortical structures during mental activity under conditions of directed changes in the brain internal medium].
    Chernysheva VA
    Fiziol Zh SSSR Im I M Sechenova; 1971 Feb; 57(2):150-8. PubMed ID: 5579573
    [No Abstract]   [Full Text] [Related]  

  • 17. [L-dopa effect in Parkinson's syndrome].
    Römer F; Bettag W; Bock WJ
    Z Allgemeinmed; 1971 Feb; 47(6):281-3. PubMed ID: 5571715
    [No Abstract]   [Full Text] [Related]  

  • 18. Contributions of neurochemistry to neurology and psychiatry. Introduction.
    Roberts E
    Fed Proc; 1973 Feb; 32(2):181-2. PubMed ID: 4143952
    [No Abstract]   [Full Text] [Related]  

  • 19. Structural-functional organization of the human brain and the pathophysiology of the Parkinsonian type hyperkineses.
    Bechtereva NP; Bondartchuk AN; Gretchin VB; Iliukhina VA; Kambarova DK; Matveev YK; Petushkov EP; Pozdeev VK; Smirnov VM; Shandurina AN
    Confin Neurol; 1972; 34(2):14-7. PubMed ID: 4579785
    [No Abstract]   [Full Text] [Related]  

  • 20. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.